Status:
COMPLETED
The South-Norway Atrial Fibrillation Screening Study
Lead Sponsor:
Sorlandet Hospital HF
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder. The most serious common complication of AF is ischemic stroke.The aim of this study is to investigate the yield of AF scr...
Detailed Description
Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder. The most serious common complication of AF is ischemic stroke. Many AF cases are undiagnosed due to the asymptomatic and ...
Eligibility Criteria
Inclusion
- Age \>65 years
- Diabetes, heart failure, hypertension, previous stroke/TIA or other cardiovascular disease (minimum 1 risk factor)
- Informed written consent for participation
Exclusion
- Chronic AF
- Lack of ability to cooperate
Key Trial Info
Start Date :
December 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04700865
Start Date
December 23 2020
End Date
June 30 2022
Last Update
December 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sorlandet Hospital
Arendal, Norway, 4809